| Name |
Recombinant Human BTN2A2/Butyrophilin 2A2 Protein Fc, CF
|
| Supplier |
R&D Systems
|
| Catalog |
8918-BT
|
| Category |
Protein
|
| Prices |
$329.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Human
|
| Nature |
Recombinant
|
| Source |
Human embryonic kidney cell, HEK293-derived Human BTN2A2 (Gln33-Val237) Accession # Q8WVV5 IEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus
|
| Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED 50 for this effect is 0.1-0.5 μg/mL.
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| Gene |
GTF2H3
|
| Sequence |
No result obtained. Gln33 inferred from enzymatic pyroglutamate treatment revealing Phe34
|
| Supplier Page |
Shop
|
Recombinant Human BTN2A2/Butyrophilin 2A2 Fc Chimera (Catalog # 8918-BT) inhibits anti-CD3 antibody-induced IL-2 secretion in human T lymphocytes. The ED 50 for this effect is 0.1-0.5 μg/mL.